Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Oncodesign Precision Medicine

ALOPM
Current price
1 EUR 0 EUR (0.00%)
Last closed 1.02 EUR
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 18 114 690 EUR
Yield for 12 month -49.24 %
1Y
3Y
5Y
10Y
15Y
ALOPM
21.11.2021 - 28.11.2021

Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company's pipeline includes OPM-101, a potentially inhibitor of the RIPK2 target, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; OPM-102, a novel inhibitor that is in preclinical studies for the treatment of cancer; and OPM-201, a potential LRRK2 inhibitor, which is in Phase 1 clinical trial for the treatment of Parkinson's disease. It is also developing drugs for the treatment of pancreatic and other cancers. The company has a strategic collaboration agreement with Navigo Proteins GmbH for the discovery and development of new systemic radiotheranostic agents. Oncodesign Precision Medicine Société anonyme was founded in 1995 and is based in Dijon, France. Address: 18 rue Jean Mazen, Dijon, France, 21000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.25 EUR

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ALOPM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 661 049 EUR
Operating Margin TTM -695.3 %
PE Ratio
Return On Assets TTM -35.51 %
PEG Ratio
Return On Equity TTM -104.58 %
Wall Street Target Price 2.25 EUR
Revenue TTM 1 734 643 EUR
Book Value 0.22 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.49 EUR
Diluted Eps TTM -0.49 EUR
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALOPM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALOPM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALOPM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 16.0458
Price Sales TTM 10.4429
Enterprise Value EBITDA -5.4493
Price Book MRQ 5.0704

Financials ALOPM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALOPM

For 52 weeks

0.92 EUR 2.38 EUR
50 Day MA 1.1 EUR
Shares Short Prior Month
200 Day MA 1.39 EUR
Short Ratio
Shares Short
Short Percent